Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insect repellent wars: Avon contests Johnson's OFF! superiority claim to Skin-So-Soft.

This article was originally published in The Tan Sheet

Executive Summary

S.C. JOHNSON OFF! DEET INSECT REPELLENT SUPERIORITY CLAIM "MISLEADING," AVON charged following Johnson's recent public relations campaign against the Skin-So-Soft insect repellent marketer. Avon "strongly refutes" Johnson's contention that "nothing has been proven safer and more effective" than DEET (N,N-diethyl-m-toluamide) as a bug spray ingredient, the company said May 7. The firm claims its citronella oil (tropical grass)- based Skin-So-Soft line "can do the job safely and effectively, without potential side effects."

You may also be interested in...



Skin-So-Soft IR3535 Insect Repellent Duration Claims "Deceptive" - Suit

Advertising claims for Avon's Skin-So-Soft Bug Guard Plus insect repellant are "materially false and deceptive," Off! Skintastic marketer S.C. Johnson alleges in an Aug. 6 counterclaim to the direct marketer's earlier lawsuit charging similar false advertising statements.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel